<DOC>
	<DOC>NCT01394042</DOC>
	<brief_summary>This is a small study to determine if probe, similar to an ultrasound probe, can detect prostate cancer more specifically than other imaging studies in patients with a positive prostate cancer biopsy.</brief_summary>
	<brief_title>Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Primary prostate cancer proven by sextant prostate biopsy Transrectal ultrasound (TRUS)guided prostate biopsy within 6 months of study enrollment Sufficient time period to complete imaging protocol and 57 day safety followup assessment without other therapeutic intervention In the judgement of principal investigator, patient able to provide informed consent and be compliant with protocol requirements ECOG status of 0 or 1 Pt &gt; 18 yrs of age Definitive or concomitant therapeutic intervention within the interval of study intervention Prior pelvic therapeutic radiation Active malignancy or therapy for malignancy with 6 months other than basal or squamous cell carcinoma of the skin Pt received radiopharmaceutical which was within 5 halflives at the time of studying imaging Known history of humanantimurineantibodies or known allergic reaction to previously received murine based products</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Biopsy proven primary prostate cancer</keyword>
</DOC>